Company Filing History:
Years Active: 2021
Title: Amaya Aleixandre: Innovator in Obesity Treatment
Introduction
Amaya Aleixandre is a notable inventor based in Madrid, Spain. She has made significant contributions to the field of health and nutrition, particularly in the treatment and prevention of obesity and related diseases. Her innovative work has implications for both the food and pharmaceutical industries.
Latest Patents
Amaya Aleixandre holds a patent for a strain of subsp. lactis CECT 8145 and its use for the treatment and/or prevention of excess weight and obesity, along with associated diseases. This invention is particularly relevant as it addresses various health issues such as metabolic syndrome, hypertension, glycemia, inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolemia, hormonal alterations, and infertility. The patent highlights the potential of incorporating this novel strain into food and pharmaceutical formulations.
Career Highlights
Amaya Aleixandre is associated with Biopolis, S.L., where she continues to advance her research and innovations. Her work is characterized by a commitment to improving public health through scientific discovery and application.
Collaborations
Amaya collaborates with several professionals in her field, including Patricia Martorell Guerola and Mª Empar Chenoll Cuadros. These collaborations enhance the research and development of her innovative solutions.
Conclusion
Amaya Aleixandre's contributions to the treatment of obesity and related diseases through her patented innovations demonstrate her dedication to improving health outcomes. Her work continues to influence the food and pharmaceutical industries positively.